Recombinant expression of antimicrobial peptides using a novel self-cleaving aggregation tag in Escherichia coli

Can J Microbiol. 2014 Mar;60(3):113-20. doi: 10.1139/cjm-2013-0652. Epub 2014 Jan 7.

Abstract

Antimicrobial peptides (AMPs) are part of the innate immune system of complex multicellular organisms. Despite the fact that AMPs show great potential as a novel class of antibiotics, the lack of a cost-effective means for their mass production limits both basic research and clinical use. In this work, we describe a novel expression system for the production of antimicrobial peptides in Escherichia coli by combining ΔI-CM mini-intein with the self-assembling amphipathic peptide 18A to drive the formation of active aggregates. Two AMPs, human β-defensin 2 and LL-37, were fused to the self-cleaving tag and expressed as active protein aggregates. The active aggregates were recovered by centrifugation and the intact antimicrobial peptides were released into solution by an intein-mediated cleavage reaction in cleaving buffer (phosphate-buffered saline supplemented with 40 mmol/L Bis-Tris, 2 mmol/L EDTA, pH 6.2). The peptides were further purified by cation-exchange chromatography. Peptides yields of 0.82 ± 0.24 and 0.59 ± 0.11 mg/L were achieved for human β-defensin 2 and LL-37, respectively, with demonstrated antimicrobial activity. Using our expression system, intact antimicrobial peptides were recovered by simple centrifugation from active protein aggregates after the intein-mediated cleavage reaction. Thus, we provide an economical and efficient way to produce intact antimicrobial peptides in E. coli.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Anti-Infective Agents / chemistry
  • Anti-Infective Agents / metabolism*
  • Antimicrobial Cationic Peptides / chemistry
  • Antimicrobial Cationic Peptides / genetics
  • Antimicrobial Cationic Peptides / metabolism*
  • Antimicrobial Cationic Peptides / pharmacology
  • Candida albicans / drug effects
  • Cathelicidins
  • Escherichia coli / chemistry
  • Escherichia coli / genetics
  • Escherichia coli / metabolism*
  • Escherichia coli K12 / drug effects
  • Gene Expression Regulation, Bacterial
  • Humans
  • Inteins
  • Peptides / chemistry
  • Peptides / genetics
  • Peptides / metabolism
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Tromethamine / analogs & derivatives
  • beta-Defensins / chemistry
  • beta-Defensins / genetics
  • beta-Defensins / metabolism
  • beta-Defensins / pharmacology

Substances

  • Anti-Infective Agents
  • Antimicrobial Cationic Peptides
  • DEFB4A protein, human
  • Peptides
  • Recombinant Proteins
  • beta-Defensins
  • peptide 18A
  • Tromethamine
  • Bistris
  • Cathelicidins